edited by Glenn J. Jaffe
Intraocular Drug Delivery studies the most recent advances in the development of ocular drug delivery systems.
Features:
- Covers current methods, clinical applications, and new delivery systems to treat and prevent proliferative eye disease
- Examines the factors that trigger and perpetuate intraocular wound healing in diseases such as proliferative vitreoretinopathy
- Reviews the results of clinical trials of new sustained delivery implants
- Analyzes the potential of intraocular drug delivery for the treatment of posterior segment diseases
Contents
General
- Retinal Drug Delivery
- Blood Retinal Barrier
- Neuroprotection
- Regulatory Issues in Drug Delivery to the Eye
Specific Delivery Systems
- Intravitreal Injection
- Anti-angiogenic Agents
- Intravitreal Antimicrobials
- Pharmacologic Retinal Reattachment with INS37217 (Denufosol Tetrasodium), a Nucleotide P2Y2 Receptor Agonist
- Cell Based Delivery Systems
- Photodynamic Therapy
- Thermal Sensitive Liposomes
- Gene Therapy for Retinal Disease
- Biodegradable Systems
- Transscleral Drug Delivery to the Retina and Choroid
- Nondegradable Intraocular Sustained Release Drug Delivery Devices
Local Drug Delivery Approach to Specific Clinical Diseases
- Age-Related Macular Degeneration
- Photodynamic Therapy Human Clinical Studies
- Age-Related Macular Degeneration Drug Delivery
- Intraocular Sustained Drug Delivery in Uveitis
- Drug Delivery for Proliferative Vitreoretinopathy: Prevention and Treatment
- Pharmacological Treatment in Diabetic Macular Edema
- Retinal Vein Occlusion
- Cytomegalovirus (CMV) Retinitis
- Endophthalmitis
Index